Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX).
- Disclosed ownership: 9.1%.
- Date of event: 31 Dec 2025.
PERCEPTIVE ADVISORS LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- TENX
- Shares outstanding
- 6,256,132 shares
- Disclosed Ownership
- 569,308 shares
- Ownership
- 9.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:00:06 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 23 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 9.1% ownership in Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share (TENX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 23 Dec 2025.
- Current filing was accepted on 17 Feb 2026, 16:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 9.1% | 569,308 | 0 | 569,308 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 9.1% | 569,308 | 0 | 569,308 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 9.1% | 569,308 | 0 | 569,308 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |